Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2000

01-10-2000 | Meeting abstract

Audit rules OK! The benefits of an internal quality audit programme in the breast screening service

Authors: S Munslow, MG Wallis

Published in: Breast Cancer Research | Special Issue 2/2000

Login to get access

Excerpt

The Warwickshire, Solihull and Coventry Breast Screening Service's success in achieving ISO 9002 certification is endorsed by its continuous programme of internal quality audits. The objective of this study is to accentuate the key reasons why internal quality audits should be performed within breast screening and to outline some of the benefits realised within our own service. …
Metadata
Title
Audit rules OK! The benefits of an internal quality audit programme in the breast screening service
Authors
S Munslow
MG Wallis
Publication date
01-10-2000
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2000
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr246

Other articles of this Special Issue 2/2000

Breast Cancer Research 2/2000 Go to the issue

Meeting abstract

Who does what? Comments from radiographers

Meeting abstract

Imaging methods to screen women with breast implants

Meeting abstract

Breast ultrasound in a "moderate risk" population

Meeting abstract

Image blur: back to basics

Meeting abstract

Surgical management

Meeting abstract

Minimally invasive treatment of the breast
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits